Erosive Esophagitis
📧 Sign up to get email alerts when something new happens for Erosive Esophagitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-10-24FDA Approved: PRILOSEC — Supplemental Application (Covis Pharma US, Inc)
FDA approved a supplemental application for Prilosec (omeprazole magnesium) submitted by Covis Pharma US, Inc.
-
FDA approval · 2016-10-24FDA Approved: ACIPHEX — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for ACIPHEX (rabeprazole sodium) submitted by Waylis Therapeutics LLC.
-
FDA approval · 2016-10-24FDA Approved: ESOMEPRAZOLE STRONTIUM — Supplemental Application (R2 Pharma, LLC)
The FDA approved a supplemental application to authorize the marketing of esomeprazole strontium, a salt form of esomeprazole, for use in th…
-
FDA approval · 2016-10-24FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for the combination product omeprazole and sodium bicarbonate from Oceanside Pharmaceuticals.
-
FDA approval · 2016-10-14FDA Approved: LANSOPRAZOLE — Original Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA Inc.'s generic lansoprazole under an original ANDA.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-08-10FDA Approved: ESOMEPRAZOLE SODIUM — Original Application (Eugia US LLC)
FDA approved Eugia US LLC's original application for esomeprazole sodium, a generic proton pump inhibitor, confirming a generic version of t…
-
FDA approval · 2016-07-25FDA Approved: LANSOPRAZOLE — Original Application (Xiromed LLC)
FDA approved the original application for a generic lansoprazole from Xiromed LLC.
-
FDA approval · 2016-07-15FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Original Application (Ajanta Pharma USA Inc.)
FDA approves Ajanta Pharma USA Inc.'s original-application generic combination of omeprazole and sodium bicarbonate for acid-related disorde…
-
FDA approval · 2016-07-15FDA Approved: EQUATE OMEPRAZOLE AND SODIUM BICARBONATE — Original Application (WALMART INC.)
FDA approved the original ANDA for Equate Omeprazole and Sodium Bicarbonate (Walmart Inc.), a store-brand combination proton pump inhibitor …
-
FDA label_change · 2016-07-08FDA Approved: DEXILANT — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Dexilant (dexlansoprazole) submitted by Takeda Pharmaceuticals America, Inc. The approval ma…
-
FDA approval · 2016-06-17FDA Approved: NEXIUM 24HR CLEARMINIS — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application for Nexium 24HR ClearMINIS (esomeprazole magnesium) from Haleon US Holdings LLC.
-
FDA approval · 2016-06-07FDA Approved: EQUATE LANSOPRAZOLE — Original Application (Wal-Mart Stores Inc)
FDA approves Equate Lansoprazole (Wal-Mart Stores Inc) under an Original Application for lansoprazole.
-
FDA approval · 2016-06-01FDA Approved: LANSOPRAZOLE — Original Application (Rite Aid Corporation)
FDA approved an original-application generic lansoprazole (a proton pump inhibitor) as an approved product; Rite Aid Corporation was the app…
-
CLINICAL_TRIALS trial_result · 2016-04-29Clinical Trial Update: A Study to Evaluate REbamiPide as an Adjuvant Regimen to Heal erosIve Reflux Esophagitis [Phase 4]
A Phase 4 study evaluating rebamipide as an adjuvant regimen to heal erosive esophagitis in gastroesophageal reflux disease has completed.
-
FDA approval · 2016-04-22FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for Esomeprazole Magnesium (generic esomeprazole magnesium) submitted by NorthStar Rx LLC.
-
FDA approval · 2016-04-21FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for esomeprazole magnesium from Aurobindo Pharma Limited, making a generic version of this proton pump…
-
FDA approval · 2016-04-04FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for Pantoprazole Sodium from NorthStar Rx LLC under ANDA202038.
-
FDA approval · 2016-03-30FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Eugia US LLC)
The FDA approved Pantoprazole sodium from Eugia US LLC under an original ANDA, making a generic pantoprazole product available. It is indica…
-
FDA approval · 2016-03-18FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (XLCare Pharmaceuticals Inc.)
FDA approved a supplemental application for Pantoprazole Sodium from XLCare Pharmaceuticals Inc., approving a change to this generic product…
-
FDA approval · 2016-02-25FDA Approved: OMEPRAZOLE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for omeprazole from Lannett Company, Inc., effectively updating the product labeling under the ANDA.
-
FDA approval · 2016-02-10FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
FDA approved a supplemental application to authorize Good Neighbor Pharmacy Omeprazole (omeprazole) as a store-brand proton pump inhibitor m…
-
FDA approval · 2016-02-03FDA Approved: PRILOSEC — Supplemental Application (Covis Pharma US, Inc)
FDA approved a supplemental application for Prilosec (omeprazole magnesium) submitted by Covis Pharma US, Inc. The approval pertains to a mo…
-
FDA approval · 2016-01-26FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals' original application for pantoprazole sodium, a generic pantoprazole product, expanding access to a pro…
-
FDA approval · 2015-12-22FDA Approved: FAMOTIDINE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for famotidine from Aurobindo Pharma Limited, enabling a generic version of famotidine to be marketed.
-
FDA approval · 2015-12-16FDA Approved: PREVACID SOLUTAB — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application to add PREVACID SOLUTAB (lansoprazole) as a soluble tablet formulation. This expands the approve…